Cholestasis as the initial presentation of relapsing polychondritis
Journal Title: Annals of Hepatology - Year 2011, Vol 10, Issue 4
Abstract
Relapsing polychondritis is an immune-mediated disease associated with inflammation in cartilaginous structures and other tissues throughout the body, particularly the ears, nose, eyes, joints, and respiratory tract. Although association with other conditions is seen in about one-third of the cases, liver involvement is not usually observed in those patients. We described a case of liver involvement in relapsing polychondritis, presenting with a predominantly cholestatic pattern. Other conditions associated with abnormal liver tests were excluded and the patient showed a prompt response to steroid therapy. We discuss the spectrum of the liver involvement in relapsing and review the literature.
Authors and Affiliations
Maria da Graça Ferronato, Leonardo Staub, Renata Teixeira Pinto Viana, Lígia da Rosa, Janaína Narciso-Schiavon, Esther Dantas-Correa
Keywords
Related Articles
- EP ID EP78090
- DOI -
- Views 144
- Downloads 0
Genetic susceptibility to hepatoxicity due to bosentan treatment in pulmonary hypertension
Background. Hepatotoxicity is a major side effect of treatment with bosentan in patients with pulmonary hypertension (PH). Bosentan is metabolized by the cytochrome CYP2C9 and inhibits the bile salt export pump, which is...
Gallstone ileus one quarter of a century post cholecystectomy
Gallstone ileus is a rare but potentially serious complication of cholelithiasis. It is usually preceded by history of biliary symptoms. It usually occurs as a result of a large gallstone creating and passing through a c...
Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina
Introduction. Hepatitis E is a disease of global distribution, with significant morbidity and mortality, whose scope and burden continue to emerge in low endemic countries. Material and methods. In 2012, we studied the p...
Shortened therapy for genotype 1 hepatitis C virus. The final answer?
Background & Aims. In hepatitis C virus genotype 1 (HCV-1) patients with a rapid viral decline within the first month of therapy, a 24-week course of pegylated interferon (PEG-IFN) alpha and ribavirin treatme...
Clinical characteristics of liver failure from a systemic cause: A report from an advanced critical care center
Background/Purpose. In Japan, acute liver failure (ALF) has generally been described using the diagnostic term, “fulminant hepatitis”, because of the fact that most cases of ALF has been thought to occur in association...